ABLIM2
Actin-binding LIM protein 2
Also known as: ABLM2_HUMAN, KIAA1808
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6H8Q1
- Gene
- ABLIM2
- Ensembl
- ENSG00000163995
- Chromosome
- 4
- Canonical length
- 611 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Mitochondria
OverviewNCBI Gene
Predicted to enable actin filament binding activity. Predicted to be involved in lamellipodium assembly. Predicted to act upstream of or within positive regulation of transcription by RNA polymerase II. Located in actin cytoskeleton. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
611 residues, UniProt reviewed canonical sequence.
>Q6H8Q1|ABLIM2
1 MSAVSQPQAA PSPLEKSPST AILCNTCGNV CKGEVLRVQD KYFHIKCFVC KACGCDLAEG
61 GFFVRQGEYI CTLDYQRLYG TRCFSCDQFI EGEVVSALGK TYHPDCFVCA VCRLPFPPGD
121 RVTFNGKECM CQKCSLPVSV GSSAHLSQGL RSCGGCGTEI KNGQALVALD KHWHLGCFKC
181 KSCGKLLNAE YISKDGLPYC EADYHAKFGI RCDSCEKYIT GRVLEAGEKH YHPSCALCVR
241 CGQMFAEGEE MYLQGSSIWH PACRQAARTE DRNKETRTSS ESIISVPASS TSGSPSRVIY
301 AKLGGEILDY RDLAALPKSK AIYDIDRPDM ISYSPYISHS AGDRQSYGEG DQDDRSYKQC
361 RTSSPSSTGS VSLGRYTPTS RSPQHYSRPG SESGRSTPSL SVLSDSKPPP STYQQAPRHF
421 HVPDTGVKDN IYRKPPIYRQ HAARRSDGED GSLDQDNRKK SSWLMLKGDA DTRTNSPDLD
481 TQSLSHSSGT DRDPLQRMAG DSFHSRFPYS KSDPLPGHGK NGLDQRNANL APCGADPDAS
541 WGMREYKIYP YDSLIVTNRI RVKLPKDVDR TRLERHLSPE EFQEVFGMSI EEFDRLALWK
601 RNDLKKKALL FLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ABLIM2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 188 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 188 nTPM
- tongue: 69 nTPM
- basal ganglia: 30 nTPM
- cerebral cortex: 24 nTPM
- spleen: 19 nTPM
- esophagus: 12 nTPM
Single-cell type
- thymic myoid cells: 1,250 nCPM
- podocytes: 1,220 nCPM
- myonuclei: 668 nCPM
- esophageal apical cells: 291 nCPM
- retinal horizontal cells: 256 nCPM
- retinal ganglion cells: 213 nCPM
Immune cell
- MAIT T-cell: 0.7 nTPM
- memory CD4 T-cell: 0.7 nTPM
- naive CD4 T-cell: 0.3 nTPM
- T-reg: 0.3 nTPM
- gdT-cell: 0.2 nTPM
- naive CD8 T-cell: 0.2 nTPM
Brain region
- cerebral cortex: 83 nTPM
- basal ganglia: 81 nTPM
- hypothalamus: 77 nTPM
- amygdala: 59 nTPM
- white matter: 53 nTPM
- pons: 51 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.47
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.17
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ABLIM2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ABLIM2 as an antibody target. Whether an autoantibody or antibody against ABLIM2 could matter depends on whether native ABLIM2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ABLIM2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ABLIM2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...